Aug 25, 2022 | Interviews
Alex Brill, a senior fellow at the American Enterprise Institute and CEO of Matrix Global Advisors, recently sat down with CAPD spokesperson Maura Keefe to discuss his latest report for CAPD.
Aug 16, 2022 | Press Releases
“The rebate rule came out of a concern about rising drug prices,” said Brill. “But it is a policy that is chock full of unintended consequences. If it were implemented, we’d have fewer discounts. That’s definitely not going to lower overall spending in the healthcare sector.”
Mar 1, 2022 | Analysis
MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill.
Feb 10, 2021 | Interviews
MGA founder and CEO Alex Brill recently appeared on The Hill event Virtually Live to discuss how complex generic medical alternatives can impact and potentially enhance the American healthcare system. In this interview, Brill talks with The Hill moderator Steve Clemons about the MGA report outlining the potential savings from accelerating US approval of complex generics.
Jan 19, 2021 | Interviews
Alex Brill recently joined Garrett Ballengee, founding executive director of the Cardinal Institute for West Virginia Policy, on their podcast “Forgotten America.” In this fascinating interview, Brill discusses the economic impacts of the opioid crisis in America, noting that the epidemic is no longer just an Appalachian problem.